CapsulateBio is building the future of oral drug delivery systems that enable biologic medicines across molecular weights and therapeutic areas to be swallowed instead of injected. From peptides to monoclonal antibodies to nucleic acids, we're developing the next generation of oral therapeutics by turning the world’s most powerful biologics into pills.
| Website | http://www.capsulate.bio |
| Employees | 8 (8 on RocketReach) |
| Founded | 2025 |
| Industry | Biotechnology Research |
Looking for a particular CapsulateBio employee's phone or email?
Mark Ellis is the Co-Founder and CEO of CapsulateBio.
8 people are employed at CapsulateBio.